That doesn't appear to be in the company's stated aims. That is not a particular area of medical need and I'd be concerned if the company was wasting resources in a well picked over area such as MRI contrast agents against much bigger players. 'Radiologic biopsy' is the point of difference with this company, and the only reason I've invested.
IBX Price at posting:
3.1¢ Sentiment: Hold Disclosure: Held
